Alkermes Plc (ALKS)
48.85
+0.52
(+1.08%)
USD |
NASDAQ |
Aug 24, 16:00
48.85
0.00 (0.00%)
After-Hours: 20:00
Alkermes EPS Diluted (Quarterly) : 0.0029 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0029 |
| March 31, 2026 | -0.40 |
| December 31, 2025 | 0.291 |
| September 30, 2025 | 0.4911 |
| June 30, 2025 | 0.5173 |
| March 31, 2025 | 0.1331 |
| December 31, 2024 | 0.8796 |
| September 30, 2024 | 0.5531 |
| June 30, 2024 | 0.5343 |
| March 31, 2024 | 0.2129 |
| December 31, 2023 | 0.6629 |
| September 30, 2023 | 0.2778 |
| June 30, 2023 | 1.382 |
| March 31, 2023 | -0.2535 |
| December 31, 2022 | -0.1719 |
| September 30, 2022 | -0.3894 |
| June 30, 2022 | -0.1839 |
| March 31, 2022 | -0.221 |
| December 31, 2021 | 0.0054 |
| September 30, 2021 | -0.1795 |
| June 30, 2021 | 0.0147 |
| March 31, 2021 | -0.1404 |
| December 31, 2020 | -0.2679 |
| September 30, 2020 | -0.0008 |
| June 30, 2020 | -0.1852 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.2445 |
| December 31, 2019 | -0.034 |
| September 30, 2019 | -0.3364 |
| June 30, 2019 | -0.2675 |
| March 31, 2019 | -0.6166 |
| December 31, 2018 | -0.0625 |
| September 30, 2018 | -0.22 |
| June 30, 2018 | -0.21 |
| March 31, 2018 | -0.40 |
| December 31, 2017 | -0.06 |
| September 30, 2017 | -0.24 |
| June 30, 2017 | -0.28 |
| March 31, 2017 | -0.45 |
| December 31, 2016 | -0.14 |
| September 30, 2016 | -0.41 |
| June 30, 2016 | -0.31 |
| March 31, 2016 | -0.51 |
| December 31, 2015 | -0.46 |
| September 30, 2015 | -0.54 |
| June 30, 2015 | -0.31 |
| March 31, 2015 | -0.21 |
| December 31, 2014 | 0.20 |
| September 30, 2014 | -0.27 |
| June 30, 2014 | 0.0242 |
| March 31, 2014 | -0.17 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | -0.3681 |
| Jazz Pharmaceuticals Plc | 2.778 |
| Prothena Corp. Plc | -0.3564 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Biogen, Inc. | 0.6557 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.501M |
| Revenue (Quarterly) | 496.01M |
| Total Expenses (Quarterly) | 495.51M |
| Enterprise Value | 9.013B |
| Gross Profit Margin (Quarterly) | 75.30% |
| Profit Margin (Quarterly) | 0.10% |
| Earnings Yield | 0.79% |
| Operating Earnings Yield | 1.74% |
| Normalized Earnings Yield | 1.006 |